Hussman Strategic Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-31,000
Closed -$605K 317
2022
Q3
$605K Hold
31,000
0.1% 244
2022
Q2
$617K Buy
+31,000
New +$693K 0.11% 245
2021
Q3
Sell
-15,500
Closed -$494K 344
2021
Q2
$494K Sell
15,500
-20,500
-57% -$651K 0.1% 266
2021
Q1
$1.27M Sell
36,000
-66,500
-65% -$2.31M 0.26% 151
2020
Q4
$3.29M Buy
102,500
+26,000
+34% +$801K 0.86% 12
2020
Q3
$2.42M Buy
+76,500
New +$2.53M 0.64% 41
2014
Q2
Sell
-26,000
Closed -$349K 209
2014
Q1
$349K Buy
26,000
+6,000
+30% +$83.1K 0.03% 162
2013
Q4
$333K Buy
20,000
+5,000
+33% +$78.1K 0.02% 163
2013
Q3
$244K Hold
15,000
0.01% 170
2013
Q2
$189K Buy
+15,000
New +$196K 0.01% 191

Other funds holding PETS

Hussman Strategic Advisors's PETS Position: Q4 2022 in Review

Hussman Strategic Advisors sold out of PetMed Express (PETS) in Q4 2022, closing a stake of 31,000 shares — an estimated $605K sold.

Hussman Strategic Advisors first reported a position in PETS in Q2 2013 and held it in 10 quarters. The position peaked at $3.29M in Q4 2020. 162 funds tracked by Wall St. Rank hold PETS as of Q4 2022.

  • Hussman Strategic Advisors reported no remaining PetMed Express position as of Q4 2022 after selling out during the quarter.
  • Hussman Strategic Advisors sold 31,000 PetMed Express shares in Q4 2022, an estimated $605K.
  • Hussman Strategic Advisors first reported a position in PetMed Express in Q2 2013 and held it in 10 quarters.
  • Hussman Strategic Advisors's PetMed Express position peaked at $3.29M in Q4 2020.
  • 162 funds tracked by Wall St. Rank held PetMed Express as of Q4 2022.

Based on Hussman Strategic Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.